ECE2020 Audio ePoster Presentations Diabetes, Obesity, Metabolism and Nutrition (285 abstracts)
New-onset diabetes mellitus after liver transplantation in the patients with acute liver failure: Is there any effect of pretransplant hypoglycemia?
Ömercan Topaloğlu 1,2 , Muhammet Cengiz 1 , Ayșe Cengiz 3 , Bahri Evren 1 , Saim Yoloğlu 4 , Sezai Yılmaz 5 & İbrahim Şahin 1
1Inonu University Medical Faculty, Endocrinology, Malatya, Turkey; 2Kocaeli Derince Training and Research Hospital, Endocrinology, Derince/Kocaeli, Turkey; 3Inonu University Medical Faculty, Internal Medicine, Malatya, Turkey; 4Inonu University Medical Faculty, Biostatistics, Malatya, Turkey; 5Inonu University Medical Faculty, General Surgery, Malatya, Turkey
Introduction: The frequency of new-onset diabetes after transplant (NODAT) is 5–30% in liver transplant recipients. We aimed to analyze the frequency and predictors of NODAT in the patients undergoing liver transplantation (LTx) due to acute liver failure(ALF), and to investigate whether pretransplant hypoglycemia had any effect on NODAT.
Materials and methods: Adult patients undergoing LTx due to ALF were analyzed retrospectively. The patients with chronic liver failure or diabetes were excluded. We measured pretransplant random blood glucose(RBG) and posttransplant fasting blood glucose(FBG). NODAT was diagnosed according to principally 1st month FBG (group 1:<100, group 2:100–125, group 3:>125 mg/dl). The participants were subgrouped according to age, gender, BM, etiology, antiviral medication, thyroid function, pretransplant RBG, donor type, immunosuppressive drug, common infection, and surgical complication.
Results: A total of 91 patients were analyzed; mean age was 33.48 (±13.35), and 52.7% (n = 48) of them was female. The etiology was Budd-Chiari syndrome in 3 (3.29%), acute viral hepatitis in 38 (41.75%), drug or toxin-related in 21 (23.07%), and other/unknown causes in 29 (31.86%) patients. The ratio of NODAT was 26.98% on the 1st month. NODAT group had a higher pretransplant RBG than the others. Pretransplant hypoglycemia did not have any effect on NODAT; however, pretransplant hyperglycemia increased the risk of NODAT by 4.065 times (P = 0.018).
Conclusions: We showed that pretransplant hyperglycemia increased the risk of NODAT by 4 times, but hypoglycemia did not affect. The frequency of NODAT decreased progressively during follow-up. We recommend perioperative glycemic control should be maintained as early as possible to manage NODAT; however, it might be complicated in such a clinical condition.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more